Skip to main content
Erschienen in: Neuroradiology 10/2004

01.10.2004 | Diagnostic Neuroradiology

Substantia innominata: MR findings in Parkinson’s disease

verfasst von: Hirobumi Oikawa, Makoto Sasaki, Shigeru Ehara, Takashi Abe

Erschienen in: Neuroradiology | Ausgabe 10/2004

Einloggen, um Zugang zu erhalten

Abstract

To elucidate MR imaging changes of the substantia innominata in Parkinson’s disease (PD), using a 1.5-T superconductive MR unit, the thickness of the substantia innominata was measured on coronal thin-section images in 44 PD patients and 20 age-matched control subjects. We also evaluated the correlation between the thickness of the substantia innominata and mental status in PD patients. Mean thickness of the substantia innominata was 2.3 mm in PD patients, and 2.5 mm in control subjects. Thinning of the substantia innominata was statistically significant in PD patients compared with control subjects, although there were large overlaps. Among the PD patients, thinning was remarkable in cases with dementia. A positive correlation between thickness of substantia innominata and score of Mini-Mental-Status-Examination was also observed in PD patients. Atrophy of the substantia innominata was demonstrated, especially in PD patients with cognitive impairment, on coronal MR images, and this is compatible with the previous pathological reports.
Literatur
1.
Zurück zum Zitat Whitehouse PJ, Hedreen JC, White CL 3rd, Price DL (1983) Basal forebrain neurons in the dementia of Parkinson’s disease. Ann Neurol 13:243–248PubMed Whitehouse PJ, Hedreen JC, White CL 3rd, Price DL (1983) Basal forebrain neurons in the dementia of Parkinson’s disease. Ann Neurol 13:243–248PubMed
2.
Zurück zum Zitat Sasaki M, Ehara S, Tamakawa Y et al (1995) MR anatomy of the substantia innominata and findings in Alzheimer disease; A preliminary report. Am J Neuroradiol 16:2001–2007PubMed Sasaki M, Ehara S, Tamakawa Y et al (1995) MR anatomy of the substantia innominata and findings in Alzheimer disease; A preliminary report. Am J Neuroradiol 16:2001–2007PubMed
3.
Zurück zum Zitat Hanyu H, Tanaka Y, Sakurai H, Takasaki M, Abe K (2002) Atrophy of the substantia innominata on magnetic resonance imaging and response to donepezil treatment in Alzheimer’s disease. Neurosci Lett 319:33–36CrossRefPubMed Hanyu H, Tanaka Y, Sakurai H, Takasaki M, Abe K (2002) Atrophy of the substantia innominata on magnetic resonance imaging and response to donepezil treatment in Alzheimer’s disease. Neurosci Lett 319:33–36CrossRefPubMed
4.
Zurück zum Zitat Hanyu H, Asano T, Sakurai H et al (2002) MR analysis of the substantia innominata in normal aging, Alzheimer disease, and other types of dementia. Am J Neuroradiol 23:27–32PubMed Hanyu H, Asano T, Sakurai H et al (2002) MR analysis of the substantia innominata in normal aging, Alzheimer disease, and other types of dementia. Am J Neuroradiol 23:27–32PubMed
5.
Zurück zum Zitat Calne DB, Snow BJ, Lee C (1992) Criteria for diagnosing Parkinson’s disease. Ann Neurol 32:S125–127PubMed Calne DB, Snow BJ, Lee C (1992) Criteria for diagnosing Parkinson’s disease. Ann Neurol 32:S125–127PubMed
6.
Zurück zum Zitat Whitehouse PJ, Price DL, Clark AW, Coyle JT, DeLong MR (1981) Alzheimer’s disease; evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol 10:122–126PubMed Whitehouse PJ, Price DL, Clark AW, Coyle JT, DeLong MR (1981) Alzheimer’s disease; evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol 10:122–126PubMed
7.
Zurück zum Zitat Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, DeLong MR (1982) Alzheimer’s disease and senile dementia: loss of neurons in the basal forebrain. Science 215:1234–1237 Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, DeLong MR (1982) Alzheimer’s disease and senile dementia: loss of neurons in the basal forebrain. Science 215:1234–1237
8.
Zurück zum Zitat Rossor MN, Garrett NJ, Johnson AL, Mountjoy CQ, Roth M, Iversen LL (1982) A post-mortem study of the cholinergic and GABA systems in senile dementia. Brain 105:313–330PubMed Rossor MN, Garrett NJ, Johnson AL, Mountjoy CQ, Roth M, Iversen LL (1982) A post-mortem study of the cholinergic and GABA systems in senile dementia. Brain 105:313–330PubMed
9.
Zurück zum Zitat White P, Hiley CR, Goodhardt MJ et al (1977) Neocortical cholinergic neurons in elderly people. Lancet I:668–671CrossRef White P, Hiley CR, Goodhardt MJ et al (1977) Neocortical cholinergic neurons in elderly people. Lancet I:668–671CrossRef
10.
Zurück zum Zitat Davies P, Maloney AJF (1976) Selective loss of central cholinergic neurons in Alzheimer’s disease. Lancet II: 1403CrossRef Davies P, Maloney AJF (1976) Selective loss of central cholinergic neurons in Alzheimer’s disease. Lancet II: 1403CrossRef
11.
Zurück zum Zitat Whitehouse PJ (1986) Clinical and neurochemical consequences of neuronal loss in the nucleus basalis of Meynert in Parkinson’s disease and Alzheimer’s disease. Adv Neurol 45:393–397 Whitehouse PJ (1986) Clinical and neurochemical consequences of neuronal loss in the nucleus basalis of Meynert in Parkinson’s disease and Alzheimer’s disease. Adv Neurol 45:393–397
12.
Zurück zum Zitat Loranger AW, Goodell H, McDowell FH et al (1972) Intellectual impairment in Parkinson’s syndrome. Brain 95:405–412PubMed Loranger AW, Goodell H, McDowell FH et al (1972) Intellectual impairment in Parkinson’s syndrome. Brain 95:405–412PubMed
13.
Zurück zum Zitat Morris JC, Drazner M, Fulling K, Grant EA, Goldring J (1989) Clinical and pathological aspects of parkinsonism in Alzheimer’s disease: a role for extranigral factors? Arch Neurol 46:651–657PubMed Morris JC, Drazner M, Fulling K, Grant EA, Goldring J (1989) Clinical and pathological aspects of parkinsonism in Alzheimer’s disease: a role for extranigral factors? Arch Neurol 46:651–657PubMed
14.
Zurück zum Zitat Bruno D, Merle R, France JA, Alain P, Yves A (1983) A subcortico-cortical cholinergic system is affected in Parkinson’s disease. Brain Res 288:213–218CrossRefPubMed Bruno D, Merle R, France JA, Alain P, Yves A (1983) A subcortico-cortical cholinergic system is affected in Parkinson’s disease. Brain Res 288:213–218CrossRefPubMed
15.
Zurück zum Zitat Hirano A, Zimmerman HM (1962) Alzheimer’s neurofibrillary changes. Arch Neurol 7:227–242PubMed Hirano A, Zimmerman HM (1962) Alzheimer’s neurofibrillary changes. Arch Neurol 7:227–242PubMed
16.
Zurück zum Zitat Steven JH, Edwin CS, Jeffrey AC, Donald WC, Andrew C, George WP (1989) Magnetic resonance imaging in dementia of Parkinson’s disease. J Neurol Neurosurg Psychiatry 52:1221–1227PubMed Steven JH, Edwin CS, Jeffrey AC, Donald WC, Andrew C, George WP (1989) Magnetic resonance imaging in dementia of Parkinson’s disease. J Neurol Neurosurg Psychiatry 52:1221–1227PubMed
17.
Zurück zum Zitat Lichter DG, Corbett AJ, Fitzgibbon GM et al (1988) Cognitive and motor dysfunction in Parkinson’s disease. Clinical, performance and computed tomographic correlations. Arch Neurol 45:854–860PubMed Lichter DG, Corbett AJ, Fitzgibbon GM et al (1988) Cognitive and motor dysfunction in Parkinson’s disease. Clinical, performance and computed tomographic correlations. Arch Neurol 45:854–860PubMed
18.
Zurück zum Zitat Hanyu H, Asano T, Sakurai H, Takasaki M, Shindo H, Abe K (2001) Magnetization transfer measurement of the subcortical gray and white matter in Parkinson’s disease with and without dementia and in progressive supranuclear palsy. Neuroradiology 43:542–546CrossRefPubMed Hanyu H, Asano T, Sakurai H, Takasaki M, Shindo H, Abe K (2001) Magnetization transfer measurement of the subcortical gray and white matter in Parkinson’s disease with and without dementia and in progressive supranuclear palsy. Neuroradiology 43:542–546CrossRefPubMed
19.
Zurück zum Zitat Carpenter MB, Sutin J (1991) Human neuroanatomy, 4th edn. Williams and Wilkins, Baltimore, pp 382–384 Carpenter MB, Sutin J (1991) Human neuroanatomy, 4th edn. Williams and Wilkins, Baltimore, pp 382–384
20.
Zurück zum Zitat Mesulam MM, Mufson EJ, Levey AI et al (1983) Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey. J Comp Neurol 214:170–197PubMed Mesulam MM, Mufson EJ, Levey AI et al (1983) Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey. J Comp Neurol 214:170–197PubMed
21.
Zurück zum Zitat Mesulam MM, Van Hoesen GW (1976) Acetylcholinesterase-rich projections from the basal forebrain of the rhesus monkey to neocortex. Brain Res 109:152–157CrossRefPubMed Mesulam MM, Van Hoesen GW (1976) Acetylcholinesterase-rich projections from the basal forebrain of the rhesus monkey to neocortex. Brain Res 109:152–157CrossRefPubMed
Metadaten
Titel
Substantia innominata: MR findings in Parkinson’s disease
verfasst von
Hirobumi Oikawa
Makoto Sasaki
Shigeru Ehara
Takashi Abe
Publikationsdatum
01.10.2004
Verlag
Springer-Verlag
Erschienen in
Neuroradiology / Ausgabe 10/2004
Print ISSN: 0028-3940
Elektronische ISSN: 1432-1920
DOI
https://doi.org/10.1007/s00234-004-1257-4

Weitere Artikel der Ausgabe 10/2004

Neuroradiology 10/2004 Zur Ausgabe

Society News

ESNR-October 2004

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.